CNS-targeted lif expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis

Molecular Therapy

Volumn 18, Issue 4, 2010, Pages 684-691

  Slaets, Helena ^a   Hendriks, Jerome J A ^a   Van Den Haute, Chris ^b   Coun, Frea ^b   Baekelandt, Veerle ^b   Stinissen, Piet ^a   Hellings, Niels ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; LEUKEMIA INHIBITORY FACTOR;

ADULT ANIMAL; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DRUG EFFICACY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; REAL TIME POLYMERASE CHAIN REACTION; SYMPTOM;

MURINAE; MUS;

EID: 77950516252     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.311     Document Type: Article

References (28)

1. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group (1998). Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis. Lancet 352: 1498-1504. (Pubitemid 28512925)
2. Trapp, BD and Nave, KA (2008). Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31: 247-269.
3. Banner, LR, Moayeri, NN and Patterson, PH (1997). Leukemia inhibitory factor is expressed in astrocytes following cortical brain injury. Exp Neurol 147: 1-9.
4. Vanderlocht, J, Hellings, N, Hendriks, JJ, Vandenabeele, F, Moreels, M, Buntinx, M et al. (2006). Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-α-induced oligodendrocyte apoptosis. J Neurosci Res 83: 763-774.
5. Butzkueven, H, Emery, B, Cipriani, T, Marriott, MP and Kilpatrick, TJ (2006). Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 53: 696-703.
6. Murphy, M, Dutton, R, Koblar, S, Cheema, S and Bartlett, P (1997). Cytokines which signal through the LIF receptor and their actions in the nervous system. Prog Neurobiol 52: 355-378. (Pubitemid 27376651)
7. Slaets, H, Dumont, D, Vanderlocht, J, Noben, JP, Leprince, P, Robben, J et al. (2008). Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3. Proteomics 8: 1237-1247. (Pubitemid 351462929)
8. Hendriks, JJ, Slaets, H, Carmans, S, de Vries, HE, Dijkstra, CD, Stinissen, P et al. (2008). Leukemia inhibitory factor modulates production of infammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 204: 52-57.
9. Kerr, BJ and Patterson, PH (2004). Potent pro-infammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp Neurol 188: 391-407.
10. Butzkueven, H, Zhang, JG, Soilu-Hanninen, M, Hochrein, H, Chionh, F, Shipham, KA et al. (2002). LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8: 613-619. (Pubitemid 34633440)
11. Linker, RA, Kruse, N, Israel, S, Wei, T, Seubert, S, Hombach, A et al. (2008). Leukemia inhibitory factor defciency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinfammation. J Immunol 180: 2204-2213.
12. Metcalf, D, Waring, P and Nicola, NA (1992). Actions of leukaemia inhibitory factor on megakaryocyte and platelet formation. Ciba Found Symp 167: 174-82; discussion 182.
13. Ding, T, Song, H, Wang, X, Khatua, A and Paria, BC (2008). Leukemia inhibitory factor ligand-receptor signaling is important for uterine receptivity and implantation in golden hamsters (Mesocricetus auratus). Reproduction 135: 41-53.
14. Ni, H, Ding, NZ, Harper, MJ and Yang, ZM (2002). Expression of leukemia inhibitory factor receptor and gp130 in mouse uterus during early pregnancy. Mol Reprod Dev 63: 143-150. (Pubitemid 34971373)
15. Mayer, P, Geissler, K, Ward, M and Metcalf, D (1993). Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. Blood 81: 3226-3233. (Pubitemid 23172903)
16. Akita, S, Conn, PM and Melmed, S (1996). Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function. J Clin Endocrinol Metab 81: 4170-4178. (Pubitemid 26380436)
17. Chesnokova, V and Melmed, S (2000). Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to infammation. Endocrinology 141: 4032-4040.
18. Pan, W, Kastin, AJ and Brennan, JM (2000). Saturable entry of leukemia inhibitory factor from blood to the central nervous system. J Neuroimmunol 106: 172-180. (Pubitemid 30256090)
19. Baekelandt, V, Claeys, A, Eggermont, K, Lauwers, E, De Strooper, B, Nuttin, B et al. (2002). Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. Hum Gene Ther 13: 841-853. (Pubitemid 34493977)
20. Prima, V, Tennant, M, Gorbatyuk, OS, Muzyczka, N, Scarpace, PJ and Zolotukhin, S (2004). Differential modulation of energy balance by leptin, ciliary neurotrophic factor, and leukemia inhibitory factor gene delivery: microarray deoxyribonucleic acid-chip analysis of gene expression. Endocrinology 145: 2035-2045. (Pubitemid 38402413)
21. Laurà, M, Gregson, NA, Curmi, Y and Hughes, RA (2002). Effcacy of leukemia inhibitory factor in experimental autoimmune neuritis. J Neuroimmunol 133: 56-59. (Pubitemid 35346728)
22. Gunawardana, DH, Basser, RL, Davis, ID, Cebon, J, Mitchell, P, Underhill, C et al. (2003). A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancer. Clin Cancer Res 9: 2056-2065. (Pubitemid 36687625)
23. Segrave, AM, Mager, DE, Charman, SA, Edwards, GA and Porter, CJ (2004). Pharmacokinetics of recombinant human leukemia inhibitory factor in sheep. J Pharmacol Exp Ther 309: 1085-1092. (Pubitemid 38669695)
24. Beretta, E, Dhillon, H, Kalra, PS and Kalra, SP (2002). Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods. Peptides 23: 975-984. (Pubitemid 34655399)
25. Azari, MF, Profyris, C, Karnezis, T, Bernard, CC, Small, DH, Cheema, SS et al. (2006). Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J Neuropathol Exp Neurol 65: 914-929. (Pubitemid 44371237)
26. Marriott, M P, Emery, B, Cate, HS, Binder, MD, Kemper, D, Wu, Q et al. (2008). Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia 56: 686-698.
27. Mayer, M, Bhakoo, K and Noble, M (1994). Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120: 143-153. (Pubitemid 24031196)
28. Baekelandt, V, Eggermont, K, Michiels, M, Nuttin, B and Debyser, Z (2003). Optimized lentiviral vector production and purifcation procedure prevents immune response after transduction of mouse brain. Gene Ther 10: 1933-1940. (Pubitemid 37337069)